Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications.
Study Design
- Tipo de estudio
- Review
- Población
- Dementia and cognitive impairment patients
- Intervención
- Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Ginkgo biloba extract (EGb 761)
- Comparador
- None
- Resultado primario
- Clinical efficacy and safety in dementia
- Dirección del efecto
- Positive
- Riesgo de sesgo
- Unclear
Abstract
Ginkgo biloba is a dioecious tree with a history of use in traditional Chinese medicine. Although the seeds are most commonly employed in traditional Chinese medicine, in recent years standardized extracts of the leaves have been widely sold as a phytomedicine in Europe and as a dietary supplement in the United States. The primary active constituents of the leaves include flavonoid glycosides and unique diterpenes known as ginkgolides; the latter are potent inhibitors of platelet activating factor. Clinical studies have shown that ginkgo extracts exhibit therapeutic activity in a variety of disorders including Alzheimer's disease, failing memory, age-related dementias, poor cerebral and ocular blood flow, congestive symptoms of premenstrual syndrome, and the prevention of altitude sickness. Due in part to its potent antioxidant properties and ability to enhance peripheral and cerebral circulation, ginkgo's primary application lies in the treatment of cerebrovascular dysfunctions and peripheral vascular disorders.
Used In Evidence Reviews
Similar Papers
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
Isorhamnetin: A review of pharmacological effects.
Archives of physical medicine and rehabilitation · 2000
Ginkgo biloba extract: mechanisms and clinical indications.
The Cochrane database of systematic reviews · 2007
Ginkgo biloba for cognitive impairment and dementia.
JAMA · 2009
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.
The Cochrane database of systematic reviews · 2009
Ginkgo biloba for cognitive impairment and dementia.
Clinical pharmacokinetics · 2013